Microbial drug resistance最新文献

{"title":"Antibiotic Susceptibility Screening and Search for Resistance Genes in <i>Yersinia pestis</i> Clinical Isolates from Plague Outbreaks in Natural Foci of Kazakhstan (1926-2003).","authors":"Zyat Abdel, Zauresh Zhumadilova, Raikhan Mussagalieva, Aigul Abdirassilova, Altyn Rysbekova, Svetlana Issaeva, Bolatbek Baitursyn, Beck Abdeliyev, Dinmukhammed Otebay, Ardak Jumagaziyeva, Bauyrzhan Toizhanov, Nurbol Shakiyev","doi":"10.1177/10766294251362277","DOIUrl":"10.1177/10766294251362277","url":null,"abstract":"<p><p><b><i>Background:</i></b> Antimicrobial resistance (AMR) is a growing global threat that complicates the treatment of infectious diseases, including plague. <i>Yersinia pestis</i>, the causative agent of plague, remains a serious public health concern in natural foci, such as those in Kazakhstan, where approximately 40% of the territory is plague-endemic. Despite the last reported human case in 2003, data on antibiotic resistance among <i>Y. pestis</i> isolates from these foci, especially historical ones, remain limited. <b><i>Materials and Methods:</i></b> A total of 75 <i>Y. pestis</i> strains were examined, including 61 isolates obtained from patients and deceased individuals during epidemic outbreaks (1926-2003) and 14 isolates from carriers and vectors in natural plague foci. Taxonomic identification was conducted using the Vitek 2 Compact 30 system. Antibiotic susceptibility was assessed by Kirby-Bauer disk diffusion and E-test methods. Extended-spectrum β-lactam (ESBL) activity was evaluated phenotypically, and resistance genes to glycopeptides and β-lactams were screened by real-time polymerase chain reaction (RT-PCR) using the BacResista GLA Detection Kit. <b><i>Results:</i></b> All isolates showed complete susceptibility (100%) to β-lactams, tetracyclines, aminoglycosides, amphenicols, glycopeptides, lincosamides, and quinolones. The overall susceptibility rate across antibiotic classes was 97.5%. Macrolides exhibited low activity (0.0-58.0%), consistent with known limitations against Gram-negative bacteria. No ESBL production was detected phenotypically, and RT-PCR screening found no resistance genes (vanA/B, mecA, tem, ctx-M-1, shv, oxa, imp, kpc, ndm, etc.). <b><i>Conclusions:</i></b> These findings confirm a lack of resistance to key antibiotic classes in historical <i>Y. pestis</i> isolates from Kazakhstan. Despite the absence of recent human cases, ongoing epizootics among wild animals highlight a persistent risk of transmission. This study, conducted for the first time in Kazakhstan, has important implications for public health preparedness and clinical management during plague outbreaks.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"287-299"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"An Outbreak of ST80 Vancomycin-Resistant <i>Enterococcus faecium</i> in a Hospital in Guangzhou, China: Clinical and Genomic Epidemiology Study from 2022 to 2023.","authors":"Yawen Deng, Xiaoying Xie, Baiji Chen, Zhixan Zhang, Jiaoni Lan, Yi Luan, Guanhua Rao, Peng Han, Chaohui Duan","doi":"10.1177/10766294251361345","DOIUrl":"10.1177/10766294251361345","url":null,"abstract":"<p><p>A notable increase in the incidence of vancomycin-resistant <i>Enterococcus faecium</i> (VREfm) was observed at a hospital in Guangzhou, China, during 2022-2023. We conducted a retrospective cross-sectional study from January 1, 2022, to August 31, 2023, to investigate the clinical and genomic characteristics of VREfm. Clinical data were extracted from electronic medical records, and infection control measures were reviewed from the relevant department. VREfm confirmation was performed using antimicrobial susceptibility testing. Genomic characteristics were analyzed via the whole-genome sequencing. The prevalence of VREfm among <i>E. faecium</i> isolates rose significantly from 13.3% (10/75) in 2022 to 26.4% (40/151) by August 2023 (<i>p</i> < 0.001). Concurrently, usage of third-generation cephalosporins increased by 8.4% (22.47 to 24.36 defined daily doses per 100 patient days), carbapenems by 34% (51.47-68.97), and vancomycin by 18% (21.15-24.97) (all <i>p</i> ≤ 0.001). Molecular analysis revealed ST80/CC17 (78%, 39/50) as the dominant clone, carrying <i>vanA</i> and virulence genes (<i>scm</i>, <i>acm,</i> and <i>fss3</i>), suggesting clonal expansion of a lineage rarely reported in Guangzhou. Our study documented an outbreak of ST80/CC17 <i>vanA</i>-positive VREfm, characterized by virulence genes (<i>scm</i>, <i>acm,</i> and <i>fss3</i>) and clonal dominance (78%, 39/50). The temporal association between reduced sodium hypochlorite disinfection (2.7-fold decline, <i>p</i> = 0.002), increased antibiotic selective pressure, and pathogen transmission highlights multifactorial drivers of this epidemic. These findings underscore the complex multifactorial nature of pathogen transmission, including the role of antibiotic use, infection control measures, and environmental factors in the spread of multidrug-resistant clones. Strengthened infection control strategies-integrating targeted disinfection, antibiotic stewardship, and genomic surveillance-are imperative to curb the spread of such multidrug-resistant clones.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"269-278"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144715148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"<i>Letter:</i> Complete Genome Sequence of <i>Klebsiella pneumoniae</i> ST15 Carrying <i>bla</i>_NDM-1 and <i>bla</i>_CTX-M-15 from Botswana, Africa.","authors":"Gherard Batisti Biffignandi, Giacomo Maria Paganotti, Pearl Ntshonga, Jonathan P Strysko, Paolo Gaibani","doi":"10.1177/10766294251364752","DOIUrl":"10.1177/10766294251364752","url":null,"abstract":"","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"300-301"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144732350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Sulfamethoxazole-Trimethoprim Resistance in <i>Haemophilus influenzae</i> Clinical Isolates in Japan: Role of FolA and Horizontal Transfer.","authors":"Takeaki Wajima, Tomokazu Ando, Emi Tanaka, Kei-Ichi Uchiya","doi":"10.1089/mdr.2025.0013","DOIUrl":"10.1089/mdr.2025.0013","url":null,"abstract":"<p><p>Sulfamethoxazole-trimethoprim (SXT) is an important empirical treatment agent against various bacterial infections. In this study, we aimed to elucidate the mechanisms underlying SXT resistance in <i>Haemophilus influenzae</i> clinical isolates from Japan, as information on such resistance remains limited. A total of 79 <i>H. influenzae</i> clinical isolates collected in 2018 and 2022 were analyzed. The SXT resistance rates were 38.7% in 2018 and 35.3% in 2022. Multilocus sequence typing analysis revealed that ST422 was the most common sequence type (36.7%), followed by ST107 (26.7%). Horizontal transfer assays using the genomic DNA or PCR-amplified fragments revealed that SXT resistance was transferred to the susceptible isolates via genomic DNA and PCR-amplified <i>folA</i> fragments, indicating that FolA mediates SXT resistance in <i>H. influenzae</i>. Site-directed mutagenesis revealed that the substitution of isoleucine at position 95 in FolA was associated with SXT resistance. All SXT-resistant isolates had an amino acid substitution at position 95 in FolA: leucine in 26 of the 30 strains, valine in 3 strains, and glycine in 1 strain. Our findings demonstrate that SXT resistance in <i>H. influenzae</i> was prevalent and can spread via horizontal transfer. Furthermore, an amino acid substitution at position 95 of FolA played a key role in conferring resistance.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"262-267"},"PeriodicalIF":1.9,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144475975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mupirocin: A Useful Antibiotic for Methicillin-Resistant <i>Staphylococcus aureus</i> Decolonization: A Narrative Review.","authors":"Yasin Saberi, Kasra Javadi, Arezoo Mirzaei, Mehrdad Halaji","doi":"10.1177/10766294251358764","DOIUrl":"10.1177/10766294251358764","url":null,"abstract":"<p><p>Mupirocin (MUP) is a topical antibiotic derived from <i>Pseudomonas fluorescens</i>, widely used for the treatment of superficial skin infections and decolonization of methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). Its unique mechanism of action, selective inhibition of bacterial isoleucyl-transfer RNA synthetase, confers high specificity with minimal risk of cross-resistance to other antibiotic classes. This narrative review provides an updated overview of MUP's chemical structure, mechanism of action, clinical efficacy, resistance mechanisms, and global resistance trends based on literature published from 2017 to 2024. Recent clinical studies confirm MUP's continued effectiveness, particularly in the decolonization of MRSA nasal infections. However, resistance, including high-level MUP resistance mediated by the <i>mupA</i> and <i>mupB</i> genes, is increasingly reported worldwide. A better understanding of resistance patterns and judicious use of MUP is essential to preserving its clinical utility in the context of rising antimicrobial resistance.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"250-261"},"PeriodicalIF":1.9,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144619079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Genetic Diversity of <i>Stenotrophomonas</i> spp. and Its Impact on Diagnosis and Treatment of Pediatric Infections.","authors":"Luiza Souza Rodrigues, Hemanoel Passarelli-Araujo, Danieli Conte, Thaís Muniz Vasconscelos, Damaris Krul, Gabriela Uessugui, Beatriz Nayra Dias de Andrade, Adriele Celine Siqueira, Érika Medeiros Dos Santos, Marinei Campos Ricieri, Fábio de Araújo Motta, Libera Maria Dalla-Costa","doi":"10.1177/10766294251359795","DOIUrl":"10.1177/10766294251359795","url":null,"abstract":"<p><p><i>Stenotrophomonas maltophilia</i> is an opportunistic, multidrug-resistant pathogen emerging in pediatric infections. Its intrinsic resistance to multiple antibiotics and genetic diversity complicates both the identification of this species and treatment strategies. We conducted genomic and phenotypic analyses of isolates of <i>Stenotrophomonas</i> spp. from pediatric patients to assess species diversity through multilocus sequence typing and average nucleotide identity analyses. Antimicrobial susceptibility and resistance mechanisms, particularly the <i>sul1</i> gene linked to sulfonamide resistance, were investigated. Our findings revealed multiple genomospecies. Of the isolates initially identified as <i>S. maltophilia</i> using matrix-assisted laser desorption ionization-time-of-flight mass spectrometry, only 58.5% were identified as such through molecular analyses. These other <i>Stenotrophomonas</i> species may not be standardized for antimicrobial susceptibility testing by the Clinical and Laboratory Standards Institute and the European Committee on Antimicrobial Susceptibility and Testing. The <i>sul1</i> gene, carried on a mobilized class 1 integron, emerged as the primary driver of trimethoprim-sulfamethoxazole resistance, raising concerns about the rapid dissemination of resistance traits. Our findings underscore the diagnostic and therapeutic challenges posed by <i>Stenotrophomonas</i> spp. infections, highlighting the urgent need for enhanced molecular diagnostics for accurate species identification and resistance profiling. Continuous surveillance and updates to clinical guidelines are essential for improving infection management in pediatric patients.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"241-249"},"PeriodicalIF":1.9,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144626625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Carriage of Extended Spectrum Beta-Lactamase and Carbapenemase Genes in Food Animals and Their Human Handlers: A One Health Perspective in a Low-Resource Setting in Africa.","authors":"Sarah Saidu, Akua Obeng Forson, Cornelia Appiah-Kwarteng, Daniel Oduro-Mensah, Michael Olu-Taiwo, Marjorie Ntiwaa Quarchie, Mary-Magdalene Osei, Paul Kwao, Noah Obeng-Nkrumah","doi":"10.1177/10766294251360947","DOIUrl":"10.1177/10766294251360947","url":null,"abstract":"<p><p>We investigated fecal colonization with third-generation cephalosporin-resistant (3GC-r) Enterobacterales and carbapenem-resistant Enterobacterales among food animals and their handlers in Ghana. A total of 252 fecal samples were collected from 211 animals and 41 human handlers across 20 farms between May and August 2023. Enterobacterales were isolated using standard methods and identified using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry fingerprints and 16SrRNA sequencing. Antibiotic susceptibility testing was done using standard methods. Extended spectrum beta-lactamase (ESBL) and carbapenemase genes were identified by PCR and sequencing. A total of 264 Enterobacterales were isolated, comprising 44 from human handlers and 220 from food animals. Among human isolates, 31 (70.5%) were 3GC-r, with 9 (20.5%) expressing the ESBL phenotype and 2 (4.5%) producing carbapenemases. The most common ESBL genes detected were <i>bla</i>_CTX-M-15 (<i>n</i> = 5/9) and <i>bla</i>_CTX-M-14 (<i>n</i> = 2/9), while carbapenemase-producing isolates harbored <i>bla</i>_NDM-1 (<i>n</i> = 1/2) or <i>bla</i>_IMP-1 (<i>n</i> = 1/2). In food animals, 94 (42.7%) of Enterobacterales isolates were 3GC-r, with 11 (5.0%) carrying ESBL genes, predominantly <i>bla</i>_CTX-M-15 (<i>n</i> = 5/11). One <i>E. coli</i> isolate exhibited carbapenemase production (<i>bla</i>_NDM-1) with an ESBL gene (<i>bla</i>_CTX-M-1). Meropenem was the most effective antibiotic agent against the study isolates (≤5% resistance). Concordance of isolate/resistance gene combinations was observed at three farms where at least one human handler and at least one farm animal carried the same 3GC-r <i>Escherichia coli</i> with the same resistance genes, including <i>bla</i>_CTX-M-15, <i>bla</i>_TEM-10, and <i>bla</i>_NDM-1. The findings indicate a potential for zoonotic transmission of resistance genes between food animals and their human handlers.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"231-240"},"PeriodicalIF":1.9,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144675288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Synergistic Antimicrobial Activity of Colistin and Amikacin with Zinc Oxide Nanoparticles and Their Posttranscriptional Regulation of <i>mcr-1</i> Gene Expression in Colistin-Resistant <i>Klebsiella pneumoniae</i>.","authors":"Jeevitha Ravi, Bhuvaneshwari Gunasekar, Jamith Basha","doi":"10.1089/mdr.2024.0117","DOIUrl":"10.1089/mdr.2024.0117","url":null,"abstract":"<p><p>The bacteria <i>Klebsiella pneumoniae</i> is encapsulated, rod-shaped, nonmotile, and Gram-negative bacilli. <i>K. pneumoniae</i> causes a variety of illnesses. They express various virulence factors such as capsules, which are primary virulence factors responsible for the pathogenicity and protection of bacteria from phagocytosis, lipopolysaccharide, which act as external membranes of the bacteria; and fimbriae-І and ІІІ which promote the binding to biological surfaces like medical devices such as ventilators. <i>K. pneumoniae</i>'s resistance to cephalosporins (3^rd and 4^th generation), quinolones, carbapenem, and colistin is increasing. Colistin is the last trait to treat multidrug-resistant <i>K. pneumoniae</i>. The monotherapy is becoming ineffective to treat infections. Plasmid-borne genes called <i>mcr-1</i> mediate colistin resistance, which is more prevalent. Colistin resistance and gene detection were done by using Epsilometry-test and conventional PCR, respectively. Amikacin was tested for synergism with colistin. Colistin with zinc oxide nanoparticle (NP) synergism was also tested. The properties of zinc oxide NPs are assessed by Fourier-transform infrared (FTIR), scanning electron microscope (SEM), and ultraviolet (UV) visible spectroscopy. Antibacterial activity of zinc oxide NPs was determined using the agar well diffusion method. In our study, we encourage combination drug therapy to treat the colistin-resistant <i>K. pneumoniae</i>. The synergistic activity of combined drugs was tested using checker-board technique. The results revealed that the synergistic activity of colistin combined with zinc oxide NPs and amikacin against colistin-resistant <i>K. pneumoniae</i> was found to be effective and can be further developed against the colistin resistant <i>K. pneumoniae</i>.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"201-210"},"PeriodicalIF":2.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144248767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"<i>In Vitro</i> Activity of Novel Antibiotics Against <i>Corynebacterium</i> spp. Clinical Isolates Responsible for Difficult-to-Treat Infections.","authors":"Ahmad Rami Bichali, Caroline Piau, Sophie Reissier, Maxime Lecourt, Anaïs Collet, Malo Penven, François Guérin, Vincent Cattoir","doi":"10.1089/mdr.2025.0046","DOIUrl":"10.1089/mdr.2025.0046","url":null,"abstract":"<p><p><i>Corynebacterium</i> species can be responsible for difficult-to-treat (DTT) infections, for which novel therapeutic options may be used. This study assessed the <i>in vitro</i> activity of newer antibiotics against <i>Corynebacterium</i> clinical isolates responsible for DTT infections between 2021 and 2023 in our center. Minimum inhibitory concentrations (MICs) were determined by the broth microdilution method or the gradient diffusion method. Interpretation was done according to the 2024 Comité de l'Antibiogramme de la Société Française de Microbiologie breakpoints. In total, 116 isolates were collected, including 73 (66%) responsible for bone and joint infections, among which half were device related. <i>C. striatum</i> was the most frequently isolated species. The activity of ceftaroline (MIC₉₀ >2 mg/L), ceftobiprole (MIC₉₀ >8 mg/L), and delafloxacin (MIC₉₀ >1 mg/L) was limited. By contrast, other molecules tested showed higher activity with low MIC₉₀ values: linezolid (MIC₉₀ ≤0.5 mg/L), tedizolid (MIC₉₀ = 0.12 mg/L), dalbavancin (MIC₉₀ = 0.12 mg/L), tigecycline (MIC₉₀ = 0.12 mg/L), eravacycline (MIC₉₀ = 0.06 mg/L), and omadacycline (MIC₉₀ = 0.5 mg/L). One <i>C. striatum</i> strain exhibited a high level of daptomycin resistance after antibiotic exposure (MIC >16 mg/L). The <i>in vitro</i> activity of most of these novel antibiotics is excellent against <i>Corynebacterium</i> clinical isolates. They could represent a real alternative for treating DTT infections due to <i>Corynebacterium</i> spp.</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"211-218"},"PeriodicalIF":2.3,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144475973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Evaluating the Antibiofilm Effects of Antibiotics on <i>Staphylococcus</i> Species from Pediatric Hematology-Oncology Patients.","authors":"Cansu Vatansever, Nilay Aksoy, Başak Adaklı Aksoy, Tunç Fışgın","doi":"10.1089/mdr.2025.0006","DOIUrl":"10.1089/mdr.2025.0006","url":null,"abstract":"<p><p>Biofilms are microbial communities and occur on different medical devices such as catheters. The formation of bacterial biofilms on medical devices leads to indwelling medical device-related infections. Since biofilm bacteria are more resistant to antibiotics than planktonic bacteria, using these antibiotics in indwelling medical device-related infections causes recurrence of infections, treatment failure, and death. Minimum inhibitory concentration (MIC) is an important reference in treating acute infections caused by planktonic bacteria. However, MIC is ineffective in indwelling medical device-related infections caused by biofilm bacteria. The study aims to demonstrate the necessity and development of effective and standard methods such as minimum biofilm prevention concentration, minimum biofilm inhibitory concentration, and minimum biofilm eradication concentration in the case of indwelling medical device-related infection. The study was conducted with 10 isolates of <i>Staphylococcus</i> species from patients who developed infections in the Pediatric Hematology-Oncology Department at Medical Park Bahcelievler Hospital. According to the study results, even if planktonic bacteria are sensitive to antibiotics, they can become resistant to this antibiotic when they are in a biofilm (<i>p</i> < 0.05, Crosstab). Also, inhibiting the growth of planktonic bacteria does not prevent biofilm formation. The study additionally revealed that inhibiting and eradicating biofilm is more difficult than preventing biofilm formation (<i>p</i> < 0.05).</p>","PeriodicalId":18701,"journal":{"name":"Microbial drug resistance","volume":" ","pages":"178-188"},"PeriodicalIF":2.3,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144033676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}